Issues in Contemporary Drug Delivery. Part II: Biopharmaceutical Considerations

Banakar UV . Issues in contemporary drug delivery. Part I: Fundamental considerations. J Pharm Technol 1990; 6: 75–81.

Levy G Antkowiak J Procknal J White D . Effect of certain tablet formulation factors on dissolution rate of the active ingredient. II. J Pharm Sci 1963; 52: 1047–51.

Solvang S Finholt P . Effect of tablet processing and formulation factors on dissolution rate of the active ingredient in human gastric juice. J Pharm Sci 1970; 59: 49–51.

Banakar UV Block LH Galinsky AM . Evaluation of a low density and a high density polyethylene as potential prolonged release tablet excipients. Pharm Technol Control Drug Release 1987; 1: 17–34.

Anwari A Banakar UV . Solid Dispersions of glyceryl guaiacolate employing methacrylate polymer (Endogit L) (abstract no. P-13). Proceedings of the 133rd Annual Meeting of the American Pharmaceutical Association, San Francisco, CA. 1986: 150.

Lagas M Duchateau AMJA . Sublingual nitroglycerin. II. In vitro and in vivo availability of Nitrostat and Nitrobaat tablets. Pharm Weekbl [Sci] 1988; 10: 254–8.

Faulkner RD Sia LL Look M . Bioequivalency of solid oral dosage forms of cefixime. Int J Pharm 1988; 42: 53–8.

Buckton G Ganderton D Shah R . In vitro dissolution of some commercially available sustained-release theophylline preparations. Int J Pharm 1988; 42: 35–9.

Deolkar E Mordier D Iten H Humbert-Droz P . Comparative tabletting properties of sixteen microcrystalline celluloses. Drug Dev Ind Pharm 1987; 13: 1847–75.

Bolhuis G Lerk C Zijlstra H Boer A . Film formation by magnesium stearate during mixing and its effect on tabletting. Pharm Weekbl [Sci] 1975; 110: 317–9.

Bolhuis G Smallenbrock A Lerk C . Interaction of tablet disintegrants and magnesium stearate during mixing. I. Effect on tablet disintegration. J Pharm Sci 1981; 70: 1328–30.

Lerk C Bolhuis G . Interaction of lubricants and colloidal silica during mixing with excipients. I. Its effects on tabletting. Pharm Acta Helv 1977; 52: 33–8.

Lerk C Bolhuis G . Effect on wettability and dissolution velocity. Pharm Acta Helv 1977; 52: 39–42.

Proost J Bolhuis G Lerk C . The effect of swelling capacity on disintegrants on the in vitro and in vivo availability of diazepam tablets containing magnesium stearate as lubricant. Int J Pharm 1983; 13: 287–90.

Marlow E Shangraw R . Dissolution of sodium salicylate from tablet matrices prepared by wet granulation and direct compression. J Pharm Sci 1967; 56: 498–502.

Patel SR . Evaluation of new tablet lubricants. Gatefosse Rep Bull Tech 1988; BT8: 92–6.

Iranloye T Parrott E . Effect of compression force, particle size and lubricants on dissolution rates. J Pharm Sci 1978; 67: 535–7.

Levy G Gumtow R . Effect of certain tablet formulation factors on dissolution rate of the active ingredient. III. Tablet lubricants. J Pharm Sci 1963; 52: 1139–42.

Igwilo C Pilpel N . Effects of coating the powder on the tensile strength, disintegration and dissolution of lactose tablets. Int J Pharm 1983; 15: 73–7.

Pilpel N Otuyemi S Kurup T . Factors affecting the disintegration and dissolution of chloroquin phosphate/starch tablets. J Pharm Pharmacol 1978; 30: 214–6.

Ravin L Shami E Intoccia A Rattie E Joseph G . Effect of polysorbate 80 on the solubility and in vivo availability of SK&F 33134-A. J Pharm Sci 1969; 58: 1242–6.

Prillig E . Effect of colorants on the solubility of modified cellulose polymers. J Pharm Sci 1969; 58: 1245–9.

Piccolo J Tawashi R . Inhibited dissolution of drug crystals by certified water-soluble dyes III. J Pharm Sci 1971; 60: 1818–21.

Tawashi R Piccolo J . Inhibited dissolution of drug crystals by certified water-soluble dyes—in vivo effect. J Pharm Sci 1972; 61: 1857–60.

Abdou HM . Dissolution, bioavailability and bioequivalence. Easton, PA: Mack Publishing, 1989: 83–5.

Ho T Hersey J . Compatibility of granules prepared by a novel method of granulation and their dissolution. J Pharm Pharmacol 1980; 32: 160–4.

Krycer I Hersey J . Grinding and granulation in a vibrating ball mill. Powder Technol 1980; 28: 93–6.

Krycer I Hersey J . Dissolution characteristics of granules prepared by a novel method of granulation. Int J Pharm Tech Prod Manuf 1981; 2 (2): 51–4.

Hasegawa S Sonobe T Katawa H Nagai T . Analysis of factors affecting dissolution of digoxin from tablets. Chem Pharm Bull 1978; 26: 2098–102.

Nixon J Hassan M . The effect of tabletting on the dissolution behavior of thiabendazole microcapsules. J Pharm Pharmacol 1980; 32: 857–60.

Chowhan Z Yang I Amaro A Chi L . Effect of moisture and crushing strength on tablet friability and in vitro dissolution. J Pharm Sci 1982; 71: 1371–3.

Chowhan Z Chatterjee B . A method for establishing in-process variable controls for optimizing tablet friability and in vitro dissolution. Int J Pharm Tech Prod Manuf 1984; 5 (2): 6–12.

Smith H Baker C Wood J . Interpretation of dissolution rate maxima: Dependence on tablet compression force. J Pharm Pharmacol 1971; 23: 536–8.

Tuladhar M Carless J Summers M . The effect of particle size compression pressure and crystal form on the dissolution rate of disintegrated rate of phenylbutazone tablets. J Pharm Pharmacol 1981; 33: 23–6.

Tuladhar M Carless J Summers M . The effect of polymorphism, particle size and compression pressure on the dissolution rate of phenylbutazone tablets. J Pharm Pharmacol 1982; 35: 269–74.

Nasipuri RN . Influence of surfactant treated starch on the disintegration and dissolution of sulphadiazine tablets. J Pharm Pharmacol 1985; 37: 212–5.

Gander B Ventouras K Gurny R Devolkar E . In vitro dissolution medium with supramicellar surfactant concentration and its relevance to in vivo absorption. Int J Pharm 1985; 27: 117–9.

Finholt P . Influence of formulation on dissolution rate. In: Leeson LJ Carstensen JT , eds. Dissolution technology. Washington, DC: American Pharmaceutical Association, 1974: 136–7.

Kellaway IW Najib NM . The influence of hydrophilic polymers on the dissolution rate of sparingly soluble drugs I: Bulk solution viscosity effects. Int J Pharm Tech Prod Manuf 1983; 4 (2): 37–9.

Shah R Pest C Ochs J . Design and evaluation of a rotating filler-stationary basket in vitro dissolution test apparatus. I. Fixed fluid volume system. J Pharm Sci 1973; 62: 671–3.

Fassihi AR . Mechanisms of disintegration and compactibility of disintegrants in a direct compression system. Int J Pharm 1986; 32: 93–6.

Newton JM Muhamed NAH . The influence of agitation intensity, particle size and pH of dissolution fluid on the in vitro release of drug from hard gelatin capsules. J Pharm Pharmacol 1984; 36: 42–4.

Pezoa R Morasso MI Ludwig B Arancibia A . Effect of mixing on the dissolution kinetics of nitrofurantoin capsules. Drug Dev Ind Pharm 1988; 14: 475–87.

Gouda HW Moustafa MA Al-Shora HI . Effect of storage on nitrofurantoin solid dosage forms. Int J Pharm 1984; 18: 213–5.

Rubino JT Halterlein LM Blanchard J . The effects of aging on the dissolution of phenytoin sodium capsule formulations. Int J Pharm 1985; 26: 165–74.

Hajratwala BR Ho DSS . Effect of aging of hydrocortisone-polyethylene glycol 4000 and hydrocortisone-polyvinylpyrrolidone dispersions. J Pharm Sci 1984; 73: 1539–41.

Knapp GG Page DP . Effect on dissolution of tablet storage in counting machines. Am J Hosp Pharm 1983; 40: 623–5.

Taborsky-Urdinola C Gray V Grady L . Effects of packaging and storage on the dissolution of model prednisone tablets. Am J Hosp Pharm 1981; 38: 1322–4.

Aguiar A Zelmar J Kinkel A . Deaggregation behavior of a relatively insoluble substituted benzoic acid and 15 sodium salt. J Pharm Sci 1967; 56: 1243–6.

Howard SA Mauger JW Phusanti L . Dissolution profiles for multisized prednisolone acetate suspensions. J Pharm Sci 1977; 66: 557–9.

Soci MM Parrott EL . Influence of viscosity on absorption from nitrofurantoin suspensions. J Pharm Sci 1980; 69: 403–6.

Barzegar-Jalali M Richards J . The effects of suspending agents on the release of aspirin from aqueous suspensions in vitro. Int J Pharm 1979; 2: 195–9.

Howard SA Mauger J Hsieh JW Amin K . Suspending agent effects on steroid suspension dissolution profiles. J Pharm Sci 1979; 68: 1475–9.

Barzegar-Jalali M Richards J . The effects of various suspending agents on the bioavailability of aspirin and salicylic acid in the rabbit. Int J Pharm 1979; 3: 133–7.

Shah N Sheth B . Effect of polymers on dissolution from drug suspensions. J Pharm Sci 1976; 65: 1618–20.

Brodin A Frank S . Drug release from O/W/O multiple emulsion system. Acta Pharm Suec 1978; 15: 111–5.

Brodin A Nyqvist-Mayer A . In vitro release studies on lidocaine aqueous solutions, micellar solutions and O/W emulsions. Acta Pharm Suec 1982; 19: 267–71.

Fokkens J deBlaey C . Drug release from nonaqueous suspensions, II. The release of methylxanthines from paraffin suspensions. Int J Pharm 1984; 18: 127–30.

Crommelin D deBlaey C . In vitro release studies of drugs suspended in nonpolar media. 1. The release of sodium chloride from suspensions in liquid paraffin. Int J Pharm 1980; 5: 305–9.

Crommelin D deBlaey C . In vitro release studies of drugs suspended in nonpolar media. II. The release of paracetamol and chloramphenicol from suspensions in liquid paraffin. Int J Pharm 1980; 6: 29–34.

Fokkens J . In vitro drug release from nonaqueous suspensions (dissertation). Utrecht, The Netherlands: University of Utrecht, 1983.

Armstrong N James K . Drug release from liquid based dosage forms. I. Int J Pharm 1980; 6: 185–90.

Armstrong N James K . Drug release from liquid based dosage forms. II. Int J Pharm 1980; 6: 195–200.

Fokkens J deBlaey C . Drug release from non-aqueous suspensions. I. Release of phenobarbital and phenobarbital sodium from paraffin suspensions. Pharm Weekbl [Sci] 1982; 4: 117–21.

Chowhan Z Pritchard R . Release of corticoids from oleagenous ointment bases containing drugs in suspensions. J Pharm Sci 1975; 64: 754–7.

Bottari F DiColo C Narmipien E Seattone M Serafini M . Release of drugs from ointments bases II. In vitro release of benzocaine from suspension-type aqueous gels. J Pharm Sci 1977; 66: 926–30.

Lippold B . Characterization and selection of the vehicle. Acta Pharm Sci 1983; 20: 29–33.

Patel U Banakar UV . Comparative in vitro dermatokinetics of ibuprofen. Proceedings of the 7th Pharmaceutical Technology Conference/Exposition, London, 1988: 54–65.

Banakar UV . In vitro release of metoprolol from various trans-dermal formulations. Proceedings of the 7th Pharmaceutical Technology Conference/Exposition, London, 1988: 28–43.

Berba J Huff S Langle J Banakar UV . In vitro dermatokinetics of selected nonsteroidal antiinflammatory analgesics (abstract). Proceedings of the 2nd Annual Meeting of the American Association of Pharmaceutical Scientists, Orlando, FL, 1988: 1725.

Davis S . Rheological aspects of topical preparations. Acta Pharm Suec 1983; 20: 32–5.

Turakka L Toikkanen E . Release of salicylic acid from aqueous triglyceride vehicles containing surfactants. Acta Pharm Suec 1983; 20: 51–6.

Brodin A Nyqvist-Mayer A Broberg F Akerman B . Development of a local anesthetic formulation. Acta Pharm Suec 1983; 20: 30–1.

Saunal H . Les promoteurs d'absorption cutanée. Gattefosse Rep Bull Tech 1988; BT10: 11–6.

Shukla A Mahashabde S . Novel uses of gelucires and transcutol in drug formulations. Gattefosse Rep Bull Tech 1988; BT10: 55–60.

Morimoto Y Sugibayashi K Hosaya K Higuchi WI . Penetration enhancing effect of azone on the transport of 5-fluorouracil across the hairless rat skin. Int J Pharm 1986; 32: 31–8.

Hamlin W Nelson E Ballard B Wagner J . Loss of sensitivity in distinguishing real differences in dissolution rates due to increasing intensity of agitation. J Pharm Sci 1962; 51: 432–6.

Levy G . Effect of certain tablet formulation factors on dissolution rate of the active ingredient. I. Importance of using appropriate agitation intensities for the in vitro dissolution rate measurements to reflect in vivo conditions. J Pharm Sci 1963; 53: 1039–42.

Underwood FL Cadwallader DE . Effects of various hydrodynamic conditions on dissolution rate determinations. J Pharm Sci 1976; 65: 697–700.

Bisaillon S Tawashi R . Influence of fluid motion on dissolution rate determinations. J Pharm Sci 1971; 60: 1874–7.

Hardwidge EA Sarapu AC Laughlin WC . Comparison of operational characteristics of different dissolution testing systems. J Pharm Sci 1978; 67: 1732–5.

Vogel J . Dissolution characteristics of various strengths of sustained release Theo-Dur tablets and Theo-24 capsules (thesis). Omaha, NE: Creighton University, 1987.

Tingstad J Gropper E Lachman L Shami E . Dissolution rate studies. III: Effect of type and intensity of agitation on dissolution rate. J Pharm Sci 1973; 62: 293–7.

Alain A Parrott EL . Effect of dissolution media on disintegration and dissolution of hvdrochlorothiazide tablets. J Pharm Sci 1971; 60: 795–9.

Banakar UV . Influence of pH on in vitro drug release characteristics (abstract no. 16). Proceedings of the 132nd Annual Meeting of the American Pharmaceutical Association, San Antonio, TX, 1985: 80.

Das SK Gupta BK . Simulation of physiological pH-time profile in in vitro dissolution study: Relationship between dissolution rate and bioavailability of controlled release dosage form. Drug Dev Ind Pharm 1988; 14: 537–44.

Singh P Desai S Simonelli A Higuchi WI . Role of wetting on the rate of drug release from inert matrices. J Pharm Sci 1968; 57: 217–9.

Short M Sharkev P Rhodes CT . Dissolution of hydrocortisone. J Pharm Sci 1972; 61: 1732–5.

Kwan K Higuchi WI Molkhia A Hoffman A . Dissolution kinetics of cholesterol in simulated bile. I. Influence of bile acid type and concentration, bile acid lecithin ratio and added electrolyte. J Pharm Sci 1977; 66: 1094–7.

Carstensen JT . Theory of dosage form dissolution. Proceedings of the Wisconsin Update Conference, “Dissolution—state of the art 1982,” University of Wisconsin, Madison, WI, 1982: 14–27.

Sarisuta N Parrott EL . Relationship of dissolution rate to viscosity of polymeric solutions. J Pharm Sci 1982; 71: 1375–8.

Braun R Parrott EL . Influence of viscosity on solubilization and dissolution rate. J Pharm Sci 1972; 61: 175–9.

Rosen A Macheras P . The effect of protein on the dissolution of phenytoin. J Pharm Pharmacol 1984; 36: 723–5.

Gibaldi M Feldman S . Establishment of sink conditions in dissolution rate determinations. J Pharm Sci 1967; 56: 1238–40.

Sarapu A Clark L . Elimination of air entrapment using USPI/rotating basket dissolution apparatus. J Pharm Sci 1980; 69: 129–32.

Cox D Douglas C Furman W Kirchhoefer R Myrick J Wells C . Guidelines for dissolution testing. Pharm Technol 1978; 2 (4): 40–6.

Hanson W . Handbook of dissolution testing. Eugene, OR: Pharmaceutical Technology Publications, 1982: 127–8.

Carstensen JT Kothari R Prasad VK Sheridan J . Time and temperature dependence of disintegration and correlation between dissolution and disintegration rate constants. J Pharm Sci 1980; 69: 290–2.

Touitou E Dunbrow M . Deviation of dissolution behavior of benzoic acid from theoretical predictions with lowering of temperature: Limitations as a model dissolution substance. Int J Pharm 1981; 9: 97–9.

Savage TS Wells CE . Automated sampling of in vitro dissolution media: Effect of sampling probes on dissolution rate of prednisone tablets. J Pharm Sci 1982; 71: 670–3.

Abdou HM . Dissolution. In: Osol A Chase GD Gennaro AR . Remington's pharmaceutical sciences. 17th ed. Easton, PA: Mack Publishing, 1985: 653–68.

Gadalla MAF El-Hameed MH Abd Ismail AA . In vivo evaluation of commercial and formulated conventional aspirin tablets. Drug Dev Ind Pharm 1986; 12: 747–81.

Goldberg AH Gibaldi M Kanig JL . Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. III: Experimental evaluation of griseofulvin-succinic acid solid solution. J Pharm Sci 1966; 55: 487–92.

Corrigan PT Bates TR . Biopharmaceutics of drugs administered in lipid-containing dosage forms. I. GI absorption of griseofulvin from an oil-in-water emulsion in the rat. J Pharm Sci 1973; 62: 1476–8.

Ritschel WA . Handbook of basic pharmacokinetics. 2nd ed. Hamilton, IL: Drug Intelligence Publications, 1980: 3, 18, 39–57.

Notari RE . Biopharmaceutics and clinical pharmacokinetics. 4th ed. New York: Marcel Dekker, 1987: 160–71.

Lindenbaum J Rund DG Butler VP Jr Tse-Eng D Saha JR . Inactivation of digoxin by the gut flora. N Engl J Med 1981; 305: 789.

Dobkin JF Saha JR Butler VP Jr Neu HC Lindenbaum J . Digoxin-inactivating bacteria-identification in human gut flora. Science 1983; 23: 325–7.

Hou JP Poole JW . β-lactam antibiotics: Their physicochemical properties and biological activities in relation to structure. J Pharm Sci 1971; 60: 503–6.

Schwartz MA Buckwalter FH . Pharmaceutics of penicillin. J Pharm Sci 1962; 51: 1119–22.

Holzman D . Body sets time for taking drugs. Insight 1987; Sept 74: 54–5.

Ritschel WA . Chronopharmacokinetics. Pharm Int 1984; 7: 116–22.

Reinberg A Smolensky MH . Circadian changes of drug disposition in man. Clin Pharmacokinet 1982; 7: 401–20.

Watanabe H Nakano S Nagai K Ogawa N . Time-dependent absorption of theophylline in man. J Clin Pharmacol 1984; 24: 509–14.

Malan J Moncrieff J Bosch E . Chronopharmacokinetics of paracetamol in normal subjects. Br J Clin Pharmacol 1985; 19: 843–5.

Klotz U Reimann IW . Chronopharmacokinetic study with prolonged infusion of midazolam. Clin Pharmacokinet 1984; 9: 469–74.

Brazzell RK Khoo K-C Schneck DW . Effect of time of dosing on the disposition of oral cibenzoline. Biopharm Drug Dispos 1985; 6: 433–40.

Lambinet I Aymard N Soulairac A Reinberg A . Chronooptimization of lithium administration in five manic depressive patients: Reduction of nephrotoxicity. Int J Chronobiol 1981; 7: 274–9.

McAllistar WAC Mitchell DM Collins JV . Prednisolone pharmacokinetics compared between night and day in asthmatic and normal subjects. Br J Clin Pharmacol 1981; 11: 303–4.

Clench J Reinberg A Dziewanowska Z Ghata J Smolensky M . Circadian changes in the bioavailability and effects of indomethacin in healthy subjects. Eur J Clin Pharmacol 1981; 20: 359–69.

Banakar UV . Specialized drug delivery systems. III. Pharmacodynamics in new drug research. Int J Pharm Technol Prod Manuf (in press).